SRI Capital is one of the few seed funds built specifically for founders who straddle the India–US corridor — investing out of Philadelphia and Hyderabad into early-stage technology startups.

The firm

SRI Capital describes itself as an “Early Stage US-India Investor”. The firm launched operations in January 2018 and made the first close of its maiden fund, SRI Capital Fund I, at $40 million in July 2018, anchored by a $20 million commitment from the family office of its founder Sashi Reddi. The fund targeted $100 million in total, raising primarily from investors in the US and Europe. According to its official website, SRI Capital Fund I has been investing in early-stage technology companies across the US and India since 2018 — but it is currently not making new investments, so founders should watch for any follow-on fund announcement.

Thesis and sweet spot

The firm exists to fill one specific gap: Indian startups selling to US enterprise customers. Reddi has long argued that Indian VCs struggle to support US-focused startups, while US VCs typically do not understand India-based tech teams — and SRI Capital plants partners on both sides of that gap.

The sweet spot is seed-stage technology: cheques of $1 million to $3 million, with capital reserved to back winners in future rounds, at a stated pace of six to eight investments a year. The firm also backs entrepreneurs who have studied or worked in the US and relocated to India to launch their companies.

Today the investment focus is squarely on transformative technology — artificial intelligence, robotics, enterprise software, and digital health.

Notable portfolio

The firm says it has backed more than 50 companies across its focus areas. Names listed on its official portfolio page include Fakespot (AI, acquired by Mozilla), EzDubs (AI, acquired by Cisco), and EdgeTensor in artificial intelligence; SoftWear Automation, Xook, and DreamVu in robotics; Phenom, Beroe, and Yellowdig in enterprise software; and HealthifyMe, CureSkin, and Smartan in digital health.

Earlier investments using the same US-India playbook include YuppTV, FabHotels, and HealthifyMe — SRI Capital was the first outside investor in all three, according to press coverage. Other portfolio names reported in the press include ThinCI (an autonomous-driving chip company), IndianMoney, LetsMD, SportsFlashes, WorkApps, and Zuppler.

People

The firm is run by Sashi Reddi, Founder and Managing Partner — a serial entrepreneur and IIT-Delhi alumnus who previously built and sold AppLabs Technologies (acquired by Computer Sciences Corporation), and earlier founded FXLabs (acquired by Foundation 9) and EZPower Systems (acquired by DocuCorp, now part of Oracle). Operating partner Doc Parghi leads from Philadelphia, giving the firm genuine partner presence in both markets. Other team members are not publicly disclosed.

Programs and perks

SRI Capital has not publicly announced any accelerator programs, founder credits, or perks schemes. Its website points founders toward its portfolio and investment focus rather than a structured application program — engagement appears to happen directly with the partners.

Why it matters for founders

If you are building enterprise technology in India for US customers — especially AI, robotics, or enterprise software — SRI Capital is one of the few seed funds explicitly built for your go-to-market, with two real exits to Mozilla and Cisco already on the board and a founder reputation for sticking with teams through pivots. The catch: Fund I is not making new investments right now, so track the firm for news of a follow-on vehicle before pitching.